Wordt geladen...
Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
It is well known that hepatitis B virus reactivation (HBVr) can occur among patients undergoing treatment for hematological malignancies (HM). The evaluation of HBVr risk in patients undergoing immunosuppressive treatments is a multidimensional process, which includes conducting an accurate clinical...
Bewaard in:
| Gepubliceerd in: | Viruses |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6784078/ https://ncbi.nlm.nih.gov/pubmed/31540124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11090858 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|